Unknown PHASE1 INTERVENTIONAL 2-arm NCT03826485

Safety, Pharmacokinetic Study of PRIC in Healthy Adult Subjects

A Randomized, Open-label, Single-dose, Crossover Study to Compare Pharmacokinetics of PRIC and Pranlukast Dry Syrup in Healthy Male Volunteers

Sponsor: SamA Pharmaceutical Co., Ltd

Conditions Healthy

Interventions PRIC Pranlukast hydrate

Updated 6 times since 2019 Last updated: Jan 30, 2019 Started: Apr 1, 2019 Primary completion: Apr 25, 2019 Completion: Jul 31, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Healthy and is currently ongoing. SamA Pharmaceutical Co., Ltd leads this study, which shows 6 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE1
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1

Status: Unknown Status → Unknown
Feb 2021 — Jul 2024 [monthly]

Unknown Status PHASE1

Status: Not Yet Recruiting → Unknown Status
Jan 2021 — Feb 2021 [monthly]

Not Yet Recruiting PHASE1

▶ Show 1 earlier version

Mar 2019 — Jan 2021 [monthly]

Not Yet Recruiting PHASE1

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

SamA Pharmaceutical Co., Ltd

Data source: SamA Pharmaceutical Co., Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seoul, South Korea